000 | 01919 a2200541 4500 | ||
---|---|---|---|
005 | 20250516011902.0 | ||
264 | 0 | _c20110809 | |
008 | 201108s 0 0 fre d | ||
022 | _a1768-3114 | ||
024 | 7 |
_a10.1016/j.patbio.2010.07.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFabre, M | |
245 | 0 | 0 |
_a[Performances of the assay MTBDRplus(®) in the surveillance of rifampicin resistance in Mycobacterium tuberculosis]. _h[electronic resource] |
260 |
_bPathologie-biologie _cApr 2011 |
||
300 |
_a94-6 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
650 | 0 | 4 |
_aCodon _xgenetics |
650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
650 | 0 | 4 | _aDNA-Directed RNA Polymerases |
650 | 0 | 4 | _aData Collection |
650 | 0 | 4 |
_aDjibouti _xepidemiology |
650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
650 | 0 | 4 |
_aFrance _xepidemiology |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aIsoniazid _xpharmacology |
650 | 0 | 4 | _aMutation, Missense |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aOxidoreductases _xgenetics |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 |
_aPolymerase Chain Reaction _xmethods |
650 | 0 | 4 | _aReagent Kits, Diagnostic |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSequence Analysis, DNA |
650 | 0 | 4 |
_aThailand _xepidemiology |
650 | 0 | 4 |
_aTuberculosis _xepidemiology |
650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xepidemiology |
700 | 1 | _aHauck, Y | |
700 | 1 | _aPourcel, C | |
700 | 1 | _aVergnaud, G | |
700 | 1 | _aVong, R | |
700 | 1 | _aSoler, C | |
773 | 0 |
_tPathologie-biologie _gvol. 59 _gno. 2 _gp. 94-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.patbio.2010.07.006 _zAvailable from publisher's website |
999 |
_c20349703 _d20349703 |